drugset / Trial / NCT01455428

Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)

NCT01455428

Phase 4 Completed 223 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To prove pregabalin is effective in relieving pain compared with placebo in subjects with postherpetic neuralgia (PHN).

Timeline

Start
2011-12
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 300 mg